Hepatitis B adjuvanted vaccine
208129/042
Phase 3 mab completed
Quick answer
Hepatitis B adjuvanted vaccine for Hepatitis B is a Phase 3 program (mab) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Hepatitis B
- Phase
- Phase 3
- Modality
- mab
- Status
- completed